T
Turk Ilac ve Serum Sanayi AS
IST:TRILC.E
Turk Ilac ve Serum Sanayi AS
IST:TRILC.E
Price:
18.25
TRY
-0.6%
Market Cap:
₺3B
Relative Value
The Relative Value of one TRILC.E stock under the Base Case scenario is hidden TRY. Compared to the current market price of 18.25 TRY, Turk Ilac ve Serum Sanayi AS is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
TRILC.E Relative Value
HIDDEN
Multiples Across Competitors
TRILC.E Competitors Multiples
Turk Ilac ve Serum Sanayi AS Competitors
Turk Ilac ve Serum Sanayi AS Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| TR |
T
|
Turk Ilac ve Serum Sanayi AS
IST:TRILC.E
|
3B TRY | 1.1 | -5.2 | 6.9 | 7.1 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
948.8B USD | 16 | 51.5 | 34.6 | 37.1 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
563B USD | 6 | 21 | 14.6 | 17.9 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
282.3B CHF | 4.6 | 30.1 | 12.7 | 14.8 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
211.8B GBP | 5.1 | 31.3 | 14.9 | 21.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
288.1B USD | 4.5 | 15.1 | 10.7 | 12.7 | |
| CH |
|
Novartis AG
SIX:NOVN
|
223B CHF | 5.1 | 19.8 | 12.4 | 16.1 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1.4T DKK | 4.3 | 13 | 9.1 | 10.5 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
218B USD | 94 | -74.6 | 333.1 | 835.4 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
146.4B USD | 2.3 | 14.9 | 7.6 | 10.3 | |
| FR |
|
Sanofi SA
PAR:SAN
|
98.2B EUR | 1.7 | 8.2 | 7.7 | 7.7 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
